LUNAC Therapeutics

LUNAC Therapeutics is a drug discovery company focused on the identification and development of next generation anticoagulant therapeutics by targeting activated Factor XII (activated clotting enzyme) to better meet patient need. Current therapies carry the risk of causing bleeding and LUNAC believes that targeting the coagulation cascade at the level of Factor XII will reduce this risk. 

Related Profiles

 Keracol

Natural chemicals company

 Cell Lane Ltd

Medical device company

 Edgetic

Artificial Intelligence software company